Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $33.79 USD
Change Today +0.05 / 0.15%
Volume 1.1M
AZN On Other Exchanges
Symbol
Exchange
Xetra
London
Stockholm
OTC US
Mexico
Berlin
As of 4:15 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - astrazeneca plc-spons adr (AZN)

Name (Connections)Board RelationshipsTitleKey Developments
Rudolph Markham 69 RelationshipsSenior Independent Non-Executive Director, Chairman of Audit Committee, Member of Nomination & Governance Committee and Member of Remuneration CommitteeAstrazeneca Announces Revised Results for the Year 2003 and First Half of 2004
10/25/04
Jean-Philippe Courtois 70 RelationshipsNon-Executive Director and Member of Audit CommitteeAstraZeneca's Marketing Of Drugs Is Investigated
03/11/03

Compensation Committee* - astrazeneca plc-spons adr (AZN)

Name (Connections)Board RelationshipsTitle
Graham Chipchase 18 RelationshipsNon-Executive Director, Chairman of Remuneration Committee and Member of Nomination & Governance Committee
Leif Johansson MSc Eng. 94 RelationshipsNon-Executive Chairman, Chairman of Nomination & Governance Committee and Member of Remuneration Committee
Rudolph Markham 69 RelationshipsSenior Independent Non-Executive Director, Chairman of Audit Committee, Member of Nomination & Governance Committee and Member of Remuneration Committee
AZN Compensation vs. Industry
1.1M
454.6K
Chief Executive Officer
680.0K
288.9K
Chief Financial Officer
Share price activity for ASTRAZENECA PLC-SPONS ADR (AZN)
52 Week Price Performance
AZN
Industry Average

Nominating Committee* - astrazeneca plc-spons adr (AZN)

Name (Connections)Board RelationshipsTitleKey Developments
Leif Johansson MSc Eng. 94 RelationshipsNon-Executive Chairman, Chairman of Nomination & Governance Committee and Member of Remuneration CommitteeAstraZeneca PLC Announces Executive Changes
07/20/15
Rudolph Markham 69 RelationshipsSenior Independent Non-Executive Director, Chairman of Audit Committee, Member of Nomination & Governance Committee and Member of Remuneration CommitteeAstraZeneca Announces Executive Changes
06/25/15
Graham Chipchase 18 RelationshipsNon-Executive Director, Chairman of Remuneration Committee and Member of Nomination & Governance CommitteeAstraZeneca Announces Management Changes
06/17/15

Corporate Governance Committee* - astrazeneca plc-spons adr (AZN)

Name (Connections)Board RelationshipsTitle
Graham Chipchase 18 RelationshipsNon-Executive Director, Chairman of Remuneration Committee and Member of Nomination & Governance Committee
Leif Johansson MSc Eng. 94 RelationshipsNon-Executive Chairman, Chairman of Nomination & Governance Committee and Member of Remuneration Committee
Rudolph Markham 69 RelationshipsSenior Independent Non-Executive Director, Chairman of Audit Committee, Member of Nomination & Governance Committee and Member of Remuneration Committee
AZN and Competitor
Insiders vs. External
Board
17%
83%
AstraZeneca PLC
9%
91%
Biogen Inc.
9%
91%
Abbott Laboratories
13%
87%
Eli Lilly and Company
10%
90%
3M Company
11%
89%
Valeant Pharmaceuticals International, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AZN:US $33.79 USD +0.05

AZN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $151.34 USD -0.23
Abbott Laboratories $50.69 USD -0.08
Biogen Inc $318.78 USD +1.78
Eli Lilly & Co $84.51 USD -0.03
Valeant Pharmaceuticals International Inc C$335.61 CAD +4.75
View Industry Companies
 

Industry Analysis

AZN

Industry Average

Valuation AZN Industry Range
Price/Earnings 66.6x
Price/Sales 3.3x
Price/Book 5.0x
Price/Cash Flow 66.6x
TEV/Sales 3.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.